Clinical Trial Update: 2- Day vs. 5- Day Terlipressin and Ceftriaxone in the Control Acute Gastroesophageal Variceal Hemorrhage [Phase 4]

View source ↗

Summary

Phase 4 trial update comparing 2-day vs 5-day terlipressin with ceftriaxone for control of acute esophageal variceal hemorrhage; current status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Variceal Bleeding
• Gastroesophageal Variceal Hemorrhage

Drugs mentioned

• Terlipressin (terlipressin)
• ceftriaxone (ceftriaxone sodium)

Snippet

Sponsor: E-DA Hospital | Conditions: Variceal Rebleeding Rate and Infections | Phase 4 | Status: UNKNOWN